Onyx Files Carfilzomib For Accelerated Approval With Two Phase III Trials Ongoing
FDA has expressed preference for having multiple confirmatory trials in the works to support an accelerated approval application.
FDA has expressed preference for having multiple confirmatory trials in the works to support an accelerated approval application.